To explore the association between TCF7L2 rs12255372 and rs7903146 single nucleotide polymorphisms (SNPs) and gastric cancer risk in Venezuelan patients.
mobility group box-containing transcription factor, which acts as an effector of the Wnt/β-catenin signaling pathway, therefore playing a pivotal role in cell development and growth regulation [2] [3] [4] . The TCF7L2 protein is also involved in blood glucose homeostasis, and their gene variants rs7903146 (C>T) and rs12255372 (G>T) [it is in high linkage disequilibrium (LD) with rs7903146] are among the most significant genetic factors influencing the risk for type 2 diabetes (T2DM) [5] [6] [7] . Although the specific role of TCF7L2 in the development of T2DM is still being investigated, evidence indicates that alterations in the Wnt signaling pathway affect insulin secretion through the reduction of the GLP-1 production [8, 9] . Moreover, aberrant Wnt signaling is involved in the pathogenesis of numerous types of human cancers [10] , and particularly to the development and progression of gastric cancer [11] . Although with contradictory conclusions, several studies have studied the association between TCF7L2 rs7903146 and rs12255372 single nucleotide polymorphisms (SNP) with susceptibility to several types of cancer, including in the prostate, breast, colon, rectum, lung and ovary [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . However, to the best of our knowledge, the participation of these SNPs in the susceptibility of gastric cancer has not been evaluated yet.
Here, we present a case-control study carried out to evaluate the role of rs7903146 and rs12255372 polymorphisms in the risk of gastric cancer in the Venezuelan population where gastric cancer is the leading cause of death due to cancer (http://www. mpps.gob.ve/).
MATERIALS AND METHODS

Subjects
A total number of 122 gastric cancer cases and 129 controls were included in this study. The group of cases consisted of paraffin-embedded intestinaltype gastric cancer samples according to Laurén's classification, which were obtained from the Pathology Department Service of the Hospital Antonio María Pineda (HAMP), Barquisimeto, Venezuela. Tumor samples were classified into well differentiated, moderately differentiated and poorly differentiated cancer depending on the degree of differentiation of the cancerous cells [22] . Patients diagnosed with chronic gastritis without evidence of gastric cancer constituted the control group. Chronic gastritis samples obtained from patients with criteria for indication of endoscopy (Gastroenterology Service of the HAMP) were evaluated according to the Sydney classification system in regard to the presence and degree of atrophic gastritis, granulocytic infiltration and lymphocytic infiltration. Two independent experts in pathology from the Department of Pathology (HAMP) evaluated all biopsies. The Bioethics Committee of the School of Health Sciences, Universidad Centroccidental Core tip: TCF7L2 transcription factor plays an important role in transcriptional activation induced by the Wnt/ β-catenin pathway, which is reported to be associated with human carcinogenesis and it is found activated in 30%-50% of gastric cancers. TCF7L2 polymorphisms rs12255372 and rs7903146 are associated with a significant risk of type 2 diabetes and in the development of several types of cancer. This is the first report of association of these TCF7L2 variants with the risk of gastric cancer. We conducted a case-control study including samples of Venezuelan patients in which the rs7903146 T allele was found associated with the risk of gastric cancer, suggesting its use as potential diagnosis biomarker in patients with this malignance.
INTRODUCTION
The transcription factor 7-like 2 (TCF7L2 or TCF-4) gene, is located on the long arm of chromosome 10q25.3 [1] . Moreover, the TCF7L2 protein is a high Lisandro Alvarado (UCLA) approved this study, and all patients gave their written informed consent to participate in the study.
Genotyping
Genomic DNA was extracted from paraffin sections of patients' tissues by MagneSil ® Genomic Fixed
Tissue System (Promega, United States), and from endoscopic biopsies using the Wizard Genomic DNA Purification kit (Promega, United States) following the manufacturer's instructions. SNPs genotyping was achieved by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. We designed primers to detect both polymorphisms using software DNAMAN version 7.212 (Lynnon Corporation) in order to amplify shorter DNA fragment, which resulted more efficient when DNA extracted from paraffinembedded tissues was used as template. The primer sets included in the reactions to amplify the rs7903146 and rs12255372 polymorphisms were: forward 5'-ACAATTAGAGAGCTAAGCACTTTTTAGGTA-3' [23] , reverse 5'-CTAAGTTACTTGCCTTCCCTG-3, and forward 5'-GAAAGTGTATTGCTATGTCCAG-3', reverse 5'-CAGAGGCCTGAGTCATTATCA-3', respectively. PCR reactions were performed in 25 µL reaction volume containing 1-2 µL of genomic DNA, 1 × Green GoTaq ® Flexi Buffer, 
RESULTS
The characteristics of the cases and controls are summarized in Table 1 . Gastric cancer tissues included 14 well-(11.5%), 56 moderately (45.9%), and 52 poorly (42.6%) differentiated carcinoma. As shown in Table 2 , the genotype distributions of rs7903146 and rs12255372 SNPs in the control group were in Hardy-Weinberg equilibrium (P > 0.05). The differences between the groups with respect to the distribution by age and sex were significant; therefore we adjusted for these variables in the subsequent analyses of the relationship between polymorphisms and gastric cancer susceptibility. Rs7903146 and rs12255372 SNPs were in moderate LD (D' < 0.644; r 2 < 0.33).
Among gastric cancer cases five samples did not amplify with the rs12255372 primer set. The rs7903146 TT genotype was significantly associated with increased risk of gastric cancer under both the codominant (OR = 3.61, 95%CI: 1.36-9.61, P = 0.01) and the recessive model (OR = 3.11, 95%CI: 1.22-7.92, P = 0.017), after adjustment for age and gender (Table 2 ). However, the recessive model of inheritance was suggested as the best-fitting one by the AIC score.
Furthermore, we evaluated the genotype distribution of rs7903146 and rs12255372 SNPs in the the dominant model (CT + TT vs CC) as the bestfitting one in the comparisons of gastritis samples with both groups of gastric cancer. Importantly, the posthoc analysis revealed that the study has acceptable statistical power (1β > 0.80 at type Ⅰ level of 0.05) to support the observed significant associations for rs7903146 genotypes. Finally, we did not identify any significant difference in genotype frequencies of rs12255372 SNP between gastric cancer and gastritis groups, even taking into account the degree of tumor differentiation (Tables 2 and 3 ).
DISCUSSION
Gastric cancer is a multifactorial disease that results gastric cancer samples divided according to the degree of histological differentiation of tumors ( (Table 3) . Moreover, rs7903146 TT genotype was associated with poorly differentiated gastric cancer in the recessive model (OR = 3.65, 95%CI: 1.25-10.62, P = 0.018). However, in these analyses the AIC score suggested 6523
July 28, 2016|Volume 22|Issue 28| WJG|www.wjgnet.com from the complex interplay of several host, bacterial, and environmental factors acting at gastric mucosa, that lead to the deregulation of many oncogenic signaling pathways [24] . Among them, the Wnt/β-catenin pathway is observed active in 30% to 50% of gastric cancer tissues and in several types of gastric cancer cell lines [25] [26] [27] . Available data confirmed that gain-of-function mutations in Wnt activators, as CTNNB1 (the gene that encodes β-catenin protein), and/or inactivating mutations and promoter hypermethylation in tumor suppressor genes (e.g., APC) lead to nuclear β-catenin accumulation and constitutive activation of the Wnt pathway in gastric cancer [11] . In the nucleus, free β-catenin binds TCF7L2 transcription factors, thereby modulating expression of genes (e.g., c-myc) implicated in proliferation, inhibition of apoptosis, tissue invasion and metastasis [28] . It is known that alterations in TCF7L2 gene and its expression, which also have a role in T2DM susceptibility, mediate carcinogenic effects through increased expression of c-myc and cyclin D [12, 29] . Moreover, while several mutations in Wnt pathway components, such as APC, CTNNB1, β-TrCP, Axin1 and Axin2 have been implicated in gastric cancer [11, 30] , the only TCF7L2 alterations so far reported in gastric tumors are somatic frameshift mutations in the exon 14 of the gene [31, 32] .
In our work the rs7903146 TT genotype was related with the risk of gastric cancer in the codominant and recessive models (OR = 3.61 and 3.11, respectively). Interestingly, the T allele at rs7903146 TCF7L2 is the most correlated genetic variant with T2DM susceptibility, which has also been associated with the risk for several types of cancer.
Although, case-control studies involving TCF7L2 rs7903146 and rs12255372 polymorphisms and cancer susceptibility have shown contradictory results, recent meta-analyses revealed that the TCF7L2 rs7903146 SNP is associated significantly with the risk of breast, prostate and colon cancer, as well as between the rs12255372 polymorphism and the susceptibility of breast cancer [33] [34] [35] [36] . Moreover, the rs12255372 SNP was not found associated with gastric cancer risk in this work.
The mechanism involving TCF7L2 gene polymorphisms with cancer risk remains unclear, however the fact that TCF7L2 gene product participates in Wnt/β-catenin signaling pathway allows to envisage their participation in carcinogenesis. Moreover, recent evidence suggests that TCF7L2 polymorphisms may be related with changes in expression levels of its gene product. Gaulton et al [37] showed that the TCF7L2 intronic SNP rs7903146 is located in an islet FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements)-enriched site and affects chromatin state and enhancer function. Furthermore, TCF7L2 rs7094463, rs10749127, and rs11196224 SNPs, which correlate with recurrence of prostate cancer in patients that were treated with radical prostatectomy, are located in potential transcriptional regulatory regions [38] . It is suggested that these DNA polymorphisms can alter the transcription factor binding sites and thus affect the TCF7L2 expression level.
Our results also suggest that the rs7903146 polymorphism (T allele) may be involved in defining the degree of differentiation of tumor cells. However, we cannot rule out that the small number of gastric adenocarcinoma samples with the TCF7L2 rs7903146 TT genotype could drive the observed association with the degree of differentiation of tumor cells when it was used codominant and recessive models. The association of genetic and epigenetic alterations with subtypes of gastric carcinoma suggests particular interactions for the development of a gastric tumor with specific degree of differentiation [39] [40] [41] . Furthermore, due to the aggressiveness of gastric cancer has been associated with the degree of differentiation of tumor cells, the evaluation of this aspect should be considered in the management of gastric cancer [22, 42] .
In conclusion, this is the first study that examines the role of TCF7L2 rs7903146 and rs12255372 SNPs related to susceptibility of gastric cancer in a Venezuelan high-risk population. Moreover, after adjustment for age and gender, we found that the rs7903146 polymorphism was significantly associated with the genetic susceptibility to gastric cancer in the Venezuelan population. This work gives additional support to understanding the participation of alterations in the Wnt/β-catenin pathway in the gastric carcinogenesis, and could represent a contribution to the identification of novel biomarkers for detection and/or monitoring progression or recurrence of gastric cancer. However, although the post-hoc analysis indicates that there was enough statistical power to support the observed associations, analysis of a larger sample size is needed to corroborate the participation of the TCF7L2 polymorphisms in the risk of gastric cancer.
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